Chris Delcher, PhD

Director, Institute for Pharmaceutical Outcomes and Policy
Department of Pharmacy Practice and Science, College of Pharmacy, University of Kentucky

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Poster(s):

• (P-027) Four Competing Definitions of Morphine Equivalence Insidiously Inhibit Evidence Synthesis

• (P-097) Characterizing Patients Using Abuse-deterrent Formulations of Extended-release Opioid Analgesics

• (P-353) Matching Study Design to Prescribing Intention: The Prevalent New User Design in Opioid Research

• (P-491) Real- world Utilization of Octreotide Immediate Releasing Use with Octreotide Long-acting Releasing